Development of Duloxetine Hydrochloride Tablets for Delayed and Complete Release Using Eudragit L 100
The purpose of the research was to optimize the preparation of duloxetine hydrochloride (duloxetine HCl) delayed release tablets. Duloxetine HCl produces a toxic substance called alpha-naphthol when duloxetine HCl is in contact with gastric fluid. Thus, duloxetine HCl when given orally needed a prot...
Saved in:
Main Authors: | M. Yasmin Begum, Ali Alqahtani, Mohammed Ghazwani, Noura Abdullah Alhamood, Umme Hani, Avanthi Jajala, Mohamed Rahamathulla |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Polymer Science |
Online Access: | http://dx.doi.org/10.1155/2021/8890503 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Some variables affecting the characteristics of Eudragit E-sodium alginate polyelectrolyte complex as a tablet matrix for diltiazem hydrochloride
by: Yusif Rehab Mohammad, et al.
Published: (2014-03-01) -
Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets
by: Vlachou Marilena, et al.
Published: (2020-03-01) -
Investigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit S 100
by: Maghraby Gamal Mohamed El, et al.
Published: (2014-03-01) -
Stability Indicating HPLC Method for Simultaneous Quantification of Trihexyphenidyl Hydrochloride, Trifluoperazine Hydrochloride and Chlorpromazine Hydrochloride from Tablet Formulation
by: P. Shetti, et al.
Published: (2010-01-01) -
Application of Eudragit RS 30D as a Potential Drug Release Retardant of Acetaminophen and Caffeine for Prolonged Duration of Comfort
by: Lailoona Jaweed, et al.
Published: (2019-01-01)